79 related articles for article (PubMed ID: 36231010)
1. PD-L1 interacts with Frizzled 6 to activate β-catenin and form a positive feedback loop to promote cancer stem cell expansion.
Fu L; Fan J; Maity S; McFadden G; Shi Y; Kong W
Oncogene; 2022 Feb; 41(8):1100-1113. PubMed ID: 35034965
[TBL] [Abstract][Full Text] [Related]
2. Retraction notice to "KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the β-catenin/STT3 signaling pathway" [Int. Immunopharmacol. 78 (2020) 106003].
Ruan Z; Liang M; Lai M; Shang L; Deng X; Su X
Int Immunopharmacol; 2023 Apr; 117():109928. PubMed ID: 36922287
[No Abstract] [Full Text] [Related]
3. Mitogen-Activated Protein Kinase and Nuclear Hormone Receptor Crosstalk in Cancer Immunotherapy.
Burgermeister E
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686465
[TBL] [Abstract][Full Text] [Related]
4. Actions of Thyroid Hormones on Thyroid Cancers.
Mousa SA; Hercbergs A; Lin HY; Keating KA; Davis PJ
Front Endocrinol (Lausanne); 2021; 12():691736. PubMed ID: 34234745
[TBL] [Abstract][Full Text] [Related]
5. Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
Chen J; Jiang CC; Jin L; Zhang XD
Ann Oncol; 2016 Mar; 27(3):409-16. PubMed ID: 26681673
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway.
Su KW; Lin HY; Chiu HC; Shen SY; ChangOu CA; Crawford DR; Yang YSH; Shih YJ; Li ZL; Huang HM; Whang-Peng J; Ho Y; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36231010
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells.
Chen YR; Chen YS; Chin YT; Li ZL; Shih YJ; Yang YSH; ChangOu CA; Su PY; Wang SH; Wu YH; Chiu HC; Lee SY; Liu LF; Whang-Peng J; Lin HY; Mousa SA; Davis PJ; Wang K
Food Chem Toxicol; 2019 Oct; 132():110693. PubMed ID: 31336132
[TBL] [Abstract][Full Text] [Related]
8. Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells.
Chin YT; Wei PL; Ho Y; Nana AW; Changou CA; Chen YR; Yang YS; Hsieh MT; Hercbergs A; Davis PJ; Shih YJ; Lin HY
Endocr Relat Cancer; 2018 May; 25(5):533-545. PubMed ID: 29555649
[TBL] [Abstract][Full Text] [Related]
9. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells.
Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ
Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161
[TBL] [Abstract][Full Text] [Related]
11. Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.
Lin SJ; Chin YT; Ho Y; Chou SY; Sh Yang YC; Nana AW; Su KW; Lim YT; Wang K; Lee SY; Shih YJ; Chen YR; Whang-Peng J; Davis PJ; Lin HY; Fu E
Food Chem Toxicol; 2018 Oct; 120():1-11. PubMed ID: 29960019
[TBL] [Abstract][Full Text] [Related]
12. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.
Gorka J; Marona P; Kwapisz O; Waligórska A; Pospiech E; Dobrucki JW; Rys J; Jura J; Miekus K
Oncogene; 2021 Dec; 40(50):6720-6735. PubMed ID: 34657130
[TBL] [Abstract][Full Text] [Related]
13. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.
Hou J; Zhao R; Xia W; Chang CW; You Y; Hsu JM; Nie L; Chen Y; Wang YC; Liu C; Wang WJ; Wu Y; Ke B; Hsu JL; Huang K; Ye Z; Yang Y; Xia X; Li Y; Li CW; Shao B; Tainer JA; Hung MC
Nat Cell Biol; 2020 Oct; 22(10):1264-1275. PubMed ID: 32929201
[TBL] [Abstract][Full Text] [Related]
14. β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion.
Du L; Lee JH; Jiang H; Wang C; Wang S; Zheng Z; Shao F; Xu D; Xia Y; Li J; Zheng Y; Qian X; Li X; Kim HR; Xing D; Liu P; Lu Z; Lyu J
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32860047
[TBL] [Abstract][Full Text] [Related]
15. Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy.
Gao Y; Nihira NT; Bu X; Chu C; Zhang J; Kolodziejczyk A; Fan Y; Chan NT; Ma L; Liu J; Wang D; Dai X; Liu H; Ono M; Nakanishi A; Inuzuka H; North BJ; Huang YH; Sharma S; Geng Y; Xu W; Liu XS; Li L; Miki Y; Sicinski P; Freeman GJ; Wei W
Nat Cell Biol; 2020 Sep; 22(9):1064-1075. PubMed ID: 32839551
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
